GlassScriptPhysician profile
Alfred Morrobel
NPI 1396237913
$1,046.79
in general payments reported to CMS, 2019-2025
16 companies · $244 in 2025
The $244 reported for 2025 was more than what 79% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $418 · 2023: $179 · 2024: $206 · 2025: $244.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $629.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $629.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $178.95 | 2022-2025 | Doc Band |
| Pfizer INC. | $157.96 | 2022-2025 | |
| Abbvie INC. | $149.11 | 2022 | |
| Merck Sharp & Dohme LLC | $107.31 | 2022-2024 | Gardasil 9, Vaxneuvance, M-M-R II |
| Cumberland Pharmaceuticals, INC. | $80.67 | 2022 | |
| Sanofi Pasteur INC. | $69.98 | 2023-2025 | |
| Glaxosmithkline, LLC. | $68.76 | 2023-2024 | Bexsero |
| Sanofi-Aventis U.S. LLC | $49.85 | 2024 | |
| Seqirus USA INC | $37.77 | 2022-2025 | Flucelvax |
| Corium, LLC | $32.81 | 2022 | |
| Verrica Pharmaceuticals INC. | $27.28 | 2024-2025 | Ycanth |
| Astrazeneca Pharmaceuticals LP | $19.89 | 2023 | Flumist Quadrivalent |
| Amphastar Pharmaceuticals, INC. | $18.54 | 2025 | |
| Alexion Pharmaceuticals, INC. | $17.48 | 2025 | Koselugo |
| Hikma Pharmaceuticals USA | $16.05 | 2023 | Ryaltris |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alk-Abello, INC | $14.38 | 2025 | Neffy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alfred Morrobel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.